Loss of responsiveness to transforming growth factor β (TGFβ) is tightly linked to tumorigenicity in a model of thyroid tumour progression

International Journal of Cancer

Volumn 65, Issue 4, 1996, Pages 525-530

  Blaydes, Jeremy P ^a   Wynford Thomas, David ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; EPITHELIUM CELL; GROWTH INHIBITION; HISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; MODEL; NONHUMAN; PRIORITY JOURNAL; RAT; THYROID CELL; THYROID TUMOR;

ANIMALS; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; THYROID NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0029886558     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960208)65:4<525::AID-IJC22>3.0.CO;2-7     Document Type: Article

References (39)

1. ARMITAGE, P. and BERRY. G., Statistical methods in medical research. Blackwell, Oxford (1971).
2. BLAYDES, J.P., SCHLUMBERGER, M., WYNFORD-THOMAS, D. and WYLLIE, F.S., Interaction between p53 and TGFβ1 in control of epithelial cell proliferation. Oncogene, 10, 307-317 (1995).
3. BOND, J.A., WYLLIE, F.S., ROWSON, J., RADULESCU, A. and WYNFORD-THOMAS, D., In vitro reconstruction of tumour initiation in a human epithelium. Oncogene. 9, 281-290 (1994).
4. BRAND, T. and SCHNEIDER, M.D., Inactive type II and type I receptors for TGFβ are dominant inhibitors of TGF β-dependent transcription. J. biol. Chem., 270, 8274-8284 (1995).
5. BURNS, J.S., BLAYDES, J.P., WRIGHT. P.A., LEMOINE, L., BOND, J.A., DILLWYN-WILLIAMS, E. and WYNFORD-THOMAS, D., Stepwise transformation of primary thyroid epithelial cells by a mutant Ha-ras oncogene: an in vitro model of tumor progression. Mol Carcinogenesis. 6, 129-139 (1992).
6. DONGHI, R., LONGONI, A., PILOTTI, S., MICHIELI, P., DELLA PORTA, G. and PIEROTTI, M.A., Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid-gland. J. clin. Invest., 91, 1753-1760 (1993).
7. FILMUS. J., ZHAO, J. and BUICK, R.N., Overexpression of H-ras oncogene induces resistance to the growth-inhibitory action of transforming growth factor beta-1 (TGFβ1) and alters the number and type of TGFβ1 receptors in rat intestinal epithelial cell clones. Oncogene. 7, 521-526 (1992).
8. FYNAN, T.M. and REISS, M., Resistance to inhibition of cell growth by transforming growth factor-β and its role in oncogenesis. Crit. Rev. Oncol., 4, 493-540 (1993).
9. GLICK, A.B., LEE, M.M., DARWICHE, N., KULKARNI, A.B., KARLSSON, S. and YLSPA, S.H., Targeted deletion of the TGF-β1 gene causes rapid progression to squamous cell carcinoma. Genes Develop., 8, 2429-2440 (1994).
10. GRUBECK-LOEBENSTEIN, B., BUCHAN. G., SADEGHI, R., KISSONERGHIS, M., LONDEI, M., TURNER, M., PIRICH, K., ROKA, R., NIEDERLE, B., KASSAI, H., WALDHÄUSI, W. and FELDMANN, M., Transforming growth factor beta regulates thyroid growth. J, clin. Invest., 83, 764-770 (1989).
11. HADDOW, S., FOWLIS, D.J., PARKINSON, K., AKHURST, R.J. and BALMAIN, A., Loss of growth control by TGFβ occurs at a late stage of mouse skin carcinogenesis and is independent of ras gene activation. Oncogens, 6, 1465-1470 (1991).
12. HÉBERT, C.D. and BIRNBAUM, L.S., Lack of correlation between sensitivity to growth inhibition and receptor number for transforming growth factor β in human squamous carcinoma cell lines. Cancer Res., 49, 3196-3202 (1989).
13. HOOSEIN, N.M., MCKNIGHT, M.K., LEVINE, A.E., MULDER, K.M., CHILDRESS, K.E., BRATTAIN, D.E. and BRATTAIN, M.G., Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-β1. Exp. Cell Res., 181, 442-453(1989).
14. Hsu, S., HUANG, F., HAFEZ, M., WINAWER, S. and FRIEDMAN, E., Colon carcinoma cells switch their response to transforming growth factor β1 with tumor progression. Cell Growth Differentiation, 5, 267-275 (1994).
15. HUANG, F., Hsu, S., YAN, Z., WINAWER, S. and FRIEDMAN, E., The capacity for growth Stimulation by TGF-β1 seen only in advanced colon cancers cannot be ascribed to mutations mAPC, DCC p53 or ras. Oncogene, 9, 3701-3706 (1994).
16. HUBBS, A.F., HAHN, F.F. and THOMASSEN, D.G., Increased resistance to transforming growth factor β accompanies neoplastic progression of rat tracheal epithelial cells. Carcinogenesis, 10, 1599-1605 (1989).
17. ITO, T., SEYAMA, T., MIZUNO, T., TSUYANA, N.. HAYASHI, Y.. DOHI, K., NAKAMURA, N. and AKIYAMA, M., Genetic alterations in thyroid tumor progression: association with p53 gene mutations. Jpn J. Cancer Res., 84, 526-531 (1993).
18. KIMCHI, A., WAMG, X.-F., WEINBERG, R.A., CHEIFETZ, S. and MASSAGUÉ, J., Absence of TGF-β receptors and growth inhibitory responses in retinoblastoma cells. Science. 240, 196-199 (1988).
19. LAHM, H. and ODARTCHBNKO, N., Role of transforming growth factor β in colorectal cancer. Growth Factors, 9, 1-9 (1993).
20. MALLIRJ, A., NIKOLIC, M., RICHARDS, S., YEUDALL, A., EDINGTON, K., VOUSDEN, K., PARKINSON, K. and OZANNE, B., Cell lines derived from SCC of head and neck tumours are sensitive to transforming growth factor beta. Presented at Conference on cellular, molecular and clinical aspects of squamous carcinomas, Glasgow (1993).
21. MANNING, A.M., WILLIAMS, A.C., GAME, S.M. and PARASKEVA, C., Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor β (TGFβ): conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGFβ. Oncogene, 6, 1471-1476 (1991).
22. MARKOWITZ, S.D., MYEROFF, L., COOPER, M.J., TRAICOFF. J., KOCHERA. M., LUTTFRBAUGH, J., SWIRIDUK, M. and WILLSON, J.K.V., A benign cultured colon adenoma bears three genetically altered colon cancer oncogenes, but progresses to tumorigenicity and transforming growth factor-beta independence without inactivating the p53 tumor suppressor gene. J. Clin. invest., 93, 1005-1013(1994).
23. MARKOUITZ, S.D., WANG, K.J., MYEROFF, L., PARSONS, R., SUN, L., LUTTERBAUGH, J., FAN, R.S., ZBOROWSKA, E., KINZLER, K.W., VOGELSTEIN, B., BRATTAIN, M. and WILLSON, J.K.V., Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science. 268, 1336-1338 (1995).
24. MASSAGUÉ, J., The transforming growth factor-β family. Ann Rev. Cell Biol, 6, 597-641 (1990).
25. MASUI, T., WAKEFIELD, L.M., LECHNER, J.F., LAVECK, M.A., SPORN, M.B. and HARRIS, C.C., Type β transforming growth factor is the primary differentiation inducing serum factor for normal human bronchial epithelial cells. Proc. nat. Acad. Sci. (Wash.), 83, 2438-2442 (1986).
26. MORRIS III, J.C., RANGANETHAN, G., HAY, I.D., NELSON, R.E. and JIAKG, N.-S., The effects of transforming growth factor-β on growth and differentiation of the continuous rat thyroid follicular cell line. FRTL-5. Endocrinology. 123, 1385-1394 (1988).
27. MULDER, K.M., RAMEY, M.K., HOOSEIN, N.M., LEVINE, A.E., HINSHAW, Z.H., BRATTAIN, D.E. and BRATTAIN, M.G., Characterisation of transforming growth factor β resistant subclones isolated from a transforming growth factor β sensitive human colon carcinoma cell line. Cancer Res., 48, 7120-7125 (1988).
28. PARK, K., KIM, S.-J., BANG, Y.-J., PARK, J.-G., KIM, N.K., ROBERTS. A.B. and SPORN, M.B., Genetic changes in the transforming growth factor β (TGFβ) type II receptor gene in human gastric cancer celis: correlation with sensitivity to growth inhibition by TGF-β. Proc. nat. Acad. Sci. (Wash.), 91, 8772-8776 (1994).
29. PEPIN, M.N., MAGOON, J. and O'CONNOR MCCOURT, M., Reduction of TGFβ sensitivity following expression of a TGFβ receptor type II antisense. J. Cell Biochem., S19a, 25 (1995).
30. ROBERTS, A.B., THOMPSON, N.L., HEINE, H., FLANDERS, C. and SPORN. M.B., Transforming growth factor-β: possible roles in carcinogenesis. Brit. J Cancer, 57, 594-600 (1988).
31. SUARDET, L., GAIDE, A.-C., CALMES, J.-M., SORDAT, B., GIVEL, J.-C., ELIASON, J.F. and ODARTCHENKO, N., Responsiveness of three newly established human colorectal cancer cell lines to transforming growth factors β1 and β2. Cancer Res., 52, 3705-3712 (1992).
32. SUN, L., Wu, G., WILLSON, J.K.V., ZBOROWSKA, E.. YANG, J., RAJKARUNANAYAKE, I., WANG, J., GENTRY, L.E., WANG, X.-F. and BRATTAIN, M.G., Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J, biol. CHem., 269, 26449-26455 (1994).
33. TATON, M., LAMY, F., ROGER, P.P. and DUMONT, J.E., General inhibition by transforming growth factor β1 of thyrotropin and cAMP responses in human thvroid cells in primary culture. Mol. Cell Endocrinol. 95.13-21 (1993).
34. TERZAGHI-HOWE, M., Changes in response to. and production of, transforming growth factor type β during neoplastic progression in cultured rat tracheal epithelial cells. Carcinogenesis, 10, 973-980 (1989).
35. WILLIAMS, D.W., WYNFORD-THOMAS, D. and WILLIAMS, E.D., Control of human thyroid follicular cell proliferation in suspension and monolayer culture. Mol Cell Endocrinol., 51, 33-40 (1987).
36. WRANA, J.L., ATTISANO, L., WIESER, R., VENTURA, F. and MASSAGUÉ. J., Mechanism of activation of the TGF-β receptor. Nature (Lond.). 370, 341-347 (1994).
37. WL, S., THEODORESCU, D., KERBEL, R.S., WILLSON, J.K.V., MULDER, K.M., HUMPHREY, L.E. and BRATTAIN, M.G., TGF-β1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector. J. Cell Biol., 116, 187-196 (1992).
38. WYLLIE, F.S., DAWSON, T., BOND. J.A., GORETZKI, P., PRIME, S., GAME, S. and WYNFORD-THOMAS. D., Correlated abnormalities of transforming growth factor β1 response and p53 expression in thyroid epithelial cell transformation. Mol Cell Endocrinol., 76, 13-21 (1991).
39. YAN, Z., WINWLR, S. and FRIEDMAN, E., Two different signal transduction pathways can be activated by transforming growth factor βl in epithelial cells. J, biol. Chem., 269, 13231-13237 (1994).